ENSYSCE BIOSCIENCES INC (ENSC)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.37-2.12%
Close 2026-11-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · ENSC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | 4.5 | 5.1 | 5.2 | 2.2 | 2.5 | 3.5 | 3.9 | — | — | — |
| Operating Expenses & Income | ||||||||||
| Selling, General & Admin | — | — | — | — | — | 18.7 | 1.2 | — | — | — |
| R&D Expenses | 12.4 | 10.4 | 7.2 | 7.6 | 19.8 | 4.7 | 4.4 | — | — | — |
| Operating Income | (12.7) | (10.2) | (6.7) | (10.7) | (24.2) | (19.9) | (1.6) | (3.3) | (1.0) | — |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | 0.0 | 1.3 | 0.4 | 0.1 | 1.3 | 1.0 | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | 0.7 | 4.2 | 3.6 | — |
| Net Interest Expenses | — | — | — | — | — | — | 0.3 | — | — | — |
| Other Non-Operating Income / Expenses | 0.0 | 0.1 | (1.3) | 0.1 | 0.0 | (9.3) | 1.5 | — | — | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | 4.6 | (0.5) | 2.7 | — |
| Income Tax Expense | — | — | — | — | — | — | 0.2 | 0.6 | 0.6 | — |
| Net Income | ||||||||||
| Minority Interest | — | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | (0.2) | — | — | — |
| Net Income | — | (10.2) | (8.0) | (10.6) | (24.2) | (29.1) | 4.3 | (1.1) | 2.1 | — |
| Per Share | ||||||||||
| Basic EPS | — | (3.98) | (11.45) | (70.40) | (139.42) | (29.64) | 0.00 | — | — | — |
| Diluted EPS | — | (3.98) | (11.45) | (70.40) | (139.42) | (1.48) | 0.00 | — | — | — |
| Revenue per Share | 0.35 | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 13.0 | 2.6 | 0.7 | 0.2 | 0.2 | 1.0 | 15.8 | — | — | — |
| Diluted Weighted Avg Shares | 13.0 | 2.6 | 0.7 | 0.2 | 0.2 | 20.2 | 16.5 | — | — | — |
| Supplemental | ||||||||||
| EBIT | (12.7) | (10.2) | (6.7) | (10.7) | (24.2) | (19.9) | (1.6) | (3.3) | (1.0) | — |
| Effective Tax Rate | — | — | — | — | — | — | 5.4% | -108.4% | 20.7% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.